# FDA Inspection 1028502 - Carter BloodCare - October 05, 2017

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/4e53127f-4eb0-4fde-b1c0-e4feb41fb9b8
Source feed: FDA_Inspections

> FDA Inspection 1028502 for Carter BloodCare on October 05, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028502
- Company Name: Carter BloodCare
- Inspection Date: 2017-10-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257153 - 2024-12-17](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/2fd9d950-6ae7-47f9-bc2f-813aec49c959)
- [FDA Inspection 1257153 - 2024-12-17](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/6fa173ff-13e7-490f-b555-99d95139fdb3)
- [FDA Inspection 1118763 - 2020-02-14](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/5af8a736-088d-41ab-bd30-828bb9121553)
- [FDA Inspection 945067 - 2015-10-06](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/66d0bf6a-cfea-41e5-903e-32493b9211e0)
- [FDA Inspection 871498 - 2014-03-26](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/eb8323d0-1afe-46db-bd0c-2888ce1e116f)

Company: https://www.keypedia.com/companies/carter-bloodcare/6cc5ca5f-4364-4676-b360-4a3f4f2a375c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d